biosynthesis of glutathione Metabolism - an overview Overview of de novo glutathione

Before we dive into storage, we need to be crystal clear on what we're dealing with

Obesity-associated improvements in metabolic profile through expansion of adipose tissue

cyanocobalamin (Vitamin B-12)Oral cyanocobalamin (Vitamin B12) is prescribed to prevent or treat vitamin B12 deficiency and to treat hyperhomocysteinemia

Neither is approved for human consumption or therapeutic use in the UK

Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols

Plasma levels of GHK-Cu decline significantly with age, from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, a 60% reduction that correlates closely with the age-related decline in regenerative capacity